Evidence map›Paper›PMID 28569190›Full record

ArticleBMC cancer2017

Single-cell mRNA profiling reveals transcriptional heterogeneity among pancreatic circulating tumour cells.

Morten Lapin, Kjersti Tjensvoll, Satu Oltedal, Milind Javle, Rune Smaaland, Bjørnar Gilje, Oddmund Nordgård

Abstract read
In one paragraph

Article in BMC cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. ctcRbase: the gene expression database of circulating tumor cells and microemboli.Database : the journal of biological databases and curation · 2020
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Morten LapinDepartment of Haematology and Oncology, Stavanger University Hospital, N-4068, Stavanger, Norway. morten.lapin@sus.no.ORCID 0000-0003-4183-0679
Kjersti TjensvollDepartment of Haematology and Oncology, Stavanger University Hospital, N-4068, Stavanger, Norway.
Satu OltedalDepartment of Haematology and Oncology, Stavanger University Hospital, N-4068, Stavanger, Norway.
Milind JavleDepartment of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA.
Rune SmaalandDepartment of Haematology and Oncology, Stavanger University Hospital, N-4068, Stavanger, Norway.
Bjørnar GiljeDepartment of Haematology and Oncology, Stavanger University Hospital, N-4068, Stavanger, Norway.
Oddmund NordgårdDepartment of Haematology and Oncology, Stavanger University Hospital, N-4068, Stavanger, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSingle-cell mRNA profiling of circulating tumour cells may contribute to a better understanding of the biology of these cells and their role in the metastatic process. In addition, such analyses may reveal new knowledge about the mechanisms underlying chemotherapy resistance and tumour progression in patients with cancer.

methodsSingle circulating tumour cells were isolated from patients with locally advanced or metastatic pancreatic cancer with immuno-magnetic depletion and immuno-fluorescence microscopy. mRNA expression was analysed with single-cell multiplex RT-qPCR. Hierarchical clustering and principal component analysis were performed to identify expression patterns.

resultsCirculating tumour cells were detected in 33 of 56 (59%) examined blood samples. Single-cell mRNA profiling of intact isolated circulating tumour cells revealed both epithelial-like and mesenchymal-like subpopulations, which were distinct from leucocytes. The profiled circulating tumour cells also expressed elevated levels of stem cell markers, and the extracellular matrix protein, SPARC. The expression of SPARC might correspond to an epithelial-mesenchymal transition in pancreatic circulating tumour cells.

conclusionThe analysis of single pancreatic circulating tumour cells identified distinct subpopulations and revealed elevated expression of transcripts relevant to the dissemination of circulating tumour cells to distant organ sites.

Indexed as

Neoplastic Cells, CirculatingBiomarkers, TumorEpithelial-Mesenchymal TransitionFemaleGene Expression Regulation, NeoplasticGenetic HeterogeneityHumansMaleNeoplasm ProteinsOsteonectinPancreatic NeoplasmsRNA, MessengerSingle-Cell AnalysisTranscription, GeneticBiomarkers, TumorNeoplasm ProteinsOsteonectinRNA, MessengerSPARC protein, humanCirculating tumour cellCTCmRNAPancreatic cancerRT-qPCRSingle-cell isolation

Identifiers

PMID28569190
PMCPMC5452374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.